The platform trial: an efficient strategy for evaluating multiple treatments
- PMID: 25799162
- DOI: 10.1001/jama.2015.2316
The platform trial: an efficient strategy for evaluating multiple treatments
Similar articles
-
Impacts on type I error rate with inappropriate use of learn and confirm in confirmatory adaptive design trials.Biom J. 2010 Dec;52(6):798-810. doi: 10.1002/bimj.200900207. Biom J. 2010. PMID: 21154897
-
Phase 0 clinical trials: an answer to drug development stagnation?J Clin Oncol. 2009 Jun 1;27(16):2586-8. doi: 10.1200/JCO.2008.21.5798. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364952 No abstract available.
-
Adaptive methods: telling "the rest of the story".J Biopharm Stat. 2010 Nov;20(6):1150-65. doi: 10.1080/10543406.2010.514457. J Biopharm Stat. 2010. PMID: 21058111
-
The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.Expert Rev Respir Med. 2015 Apr;9(2):195-204. doi: 10.1586/17476348.2015.1024663. Epub 2015 Mar 10. Expert Rev Respir Med. 2015. PMID: 25757365 Review.
-
Clinical trial simulation: a review.Clin Pharmacol Ther. 2010 Aug;88(2):166-82. doi: 10.1038/clpt.2010.114. Epub 2010 Jul 7. Clin Pharmacol Ther. 2010. PMID: 20613720 Review.
Cited by
-
Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update.Clin Trials. 2019 Dec;16(6):645-656. doi: 10.1177/1740774519871471. Epub 2019 Aug 26. Clin Trials. 2019. PMID: 31450957 Free PMC article.
-
ERS International Congress 2021: highlights from the Respiratory Infections Assembly.ERJ Open Res. 2022 May 23;8(2):00642-2021. doi: 10.1183/23120541.00642-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35615420 Free PMC article. Review.
-
Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis.Front Pharmacol. 2019 Mar 28;10:301. doi: 10.3389/fphar.2019.00301. eCollection 2019. Front Pharmacol. 2019. PMID: 30983998 Free PMC article. Review.
-
Paediatric cardiopulmonary bypass surgery: the challenges of heterogeneity and identifying a meaningful endpoint for clinical trials.Intensive Care Med. 2017 Jan;43(1):113-115. doi: 10.1007/s00134-016-4622-y. Epub 2016 Nov 18. Intensive Care Med. 2017. PMID: 27864614 No abstract available.
-
Model-Informed Drug Development for Malaria Therapeutics.Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:567-582. doi: 10.1146/annurev-pharmtox-010715-103429. Epub 2017 Oct 6. Annu Rev Pharmacol Toxicol. 2018. PMID: 28992431 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical